Gerresheimer (ETR:GXI) Sets New 12-Month High at $86.70

Gerresheimer AG (ETR:GXI) hit a new 52-week high during trading on Thursday . The company traded as high as €86.70 ($97.42) and last traded at €86.50 ($97.19), with a volume of 122303 shares. The stock had previously closed at €84.60 ($95.06).

A number of equities research analysts have commented on GXI shares. Credit Suisse Group set a €84.00 ($94.38) price objective on Gerresheimer and gave the stock a “buy” rating in a research report on Wednesday, April 15th. JPMorgan Chase & Co. set a €59.10 ($66.40) price objective on Gerresheimer and gave the stock a “neutral” rating in a research report on Monday, April 13th. Independent Research set a €72.00 ($80.90) price objective on Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, April 16th. Deutsche Bank set a €92.00 ($103.37) price objective on Gerresheimer and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Finally, Goldman Sachs Group set a €90.00 ($101.12) price objective on Gerresheimer and gave the stock a “buy” rating in a research report on Monday, June 29th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of €75.89 ($85.27).

The firm has a market capitalization of $2.72 billion and a price-to-earnings ratio of -196.97. The company has a current ratio of 0.61, a quick ratio of 0.37 and a debt-to-equity ratio of 119.95. The company has a fifty day moving average price of €77.56 and a 200-day moving average price of €69.48.

Gerresheimer Company Profile (ETR:GXI)

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Further Reading: What are the qualifications of a portfolio manager?

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.